Skip to main content
. 2019 Dec;15(12):656–665.

Table 2.

Risk Factors for PNR to Anti-TNF Therapy

Etiology Risk for PNR to Anti-TNF Terapy
Drug-related factors Low drug concentrations (pharmacoki-netics): nonimmune clearance, immu-nogenicity (development of antidrug antibodies)
Adequate drug concentrations (pharma-codynamics): mechanistic failure
Patient-related factors Smoking, obesity
Disease-related factors Longstanding disease (>2 years), isolated small bowel disease, upper gastrointestinal involvement, severe intestinal infammation, hypoalbuminemia
PNR, primary nonresponse; TNF, tumor necrosis factor